#USA #Fort Lauderdale #Anju Software #Luminee #SCOPE EU 2025

Anju Software Unveils Its Cutting-Edge AI Engine: Luminee

Anju Software has recently launched Luminee, a groundbreaking AI-driven engine designed to automate the creation of Electronic Data Capture (EDC) databases with remarkable efficiency. This innovative technology assists in transitioning from initial protocol ingestion to thorough validation, ultimately reducing the often lengthy study build times from months down to just days.

Award-Winning Innovation

Luminee has already gained recognition in the industry, being awarded the SCOPE EU 2025 Innovation Award. This accolade highlights the engine’s substantial role in streamlining clinical operations and transforming the methodologies used by sponsors and Clinical Research Organizations (CROs) for database development.

For years, professionals in clinical research have faced the challenge of protracted, manual build cycles that consume excessive resources and extend trial timelines. Luminee effectively addresses these pain points by utilizing cutting-edge technology to read and analyze study protocols, automating the generation of validated, inspection-ready EDC databases seamlessly, and incorporating elements such as visit structures, forms, edit checks, and validation documentation within minimal time frames.

A New Era for Clinical Operations

Laura Acosta, Senior Vice President of Product at Anju Software, emphasized the transformative nature of Luminee, stating, "Luminee represents a major evolution for clinical operations. As teams are increasingly pressured to deliver results rapidly with fewer resources, this innovative tool offers a solution to eliminate one of their most significant challenges. It is designed to construct with precision, expedite timelines, and uphold the quality and compliance needed in the industry."

By leveraging Luminee, sponsors and CROs can expect to see remarkable benefits:

• - Up to 90% Faster Study Builds: The AI-driven protocol ingestion significantly truncates build times, allowing for swifter project initiation.
• - Reduced Dependency on Technical Resources: The automation of manual tasks diminishes reliance on technical personnel, freeing them to focus on more strategic responsibilities.
• - Automated Validation Documentation: This feature aligns with regulatory requirements, ensuring that all documentation is compliant and streamlined.
• - Integration Across Anju's Ecosystem: Luminee integrates seamlessly with Anju’s other eClinical solutions like TrialMaster and TrialBuilder.
• - Enhanced Data Quality and Compliance: Built in alignment with 21 CFR Part 11, GCP, HIPAA, and GDPR standards, ensuring high-quality data integrity and protection.

Tailored Solutions for Research Organizations

Anju Software offers Luminee through its clinical solutions, providing data managers, clinical operations teams, and research institutes with a scalable method to enhance study builds while diminishing risk factors. With the use of this innovative engine, clients can anticipate a significant increase in their Return on Employment across their operational portfolios, enhancing overall efficiency and effectiveness.

Request a Demo

For more information regarding Luminee or to schedule a live demonstration, interested parties can visit the official Anju Software website and explore the capabilities of this pioneering AI tool.

About Anju Software

Anju Software is known for its customer-centric approach, delivering flexible life sciences solutions targeted at clinical research, medical affairs, and data science. The company’s flagship products, including TrialMaster, IRMS MAX, and TA Scan, play a critical role in simplifying the complexities associated with drug and device discovery and commercialization. With a diverse team of industry experts and a comprehensive lineup of adaptable products, Anju empowers its clients to foster innovation, ensure efficiency, and maintain compliance in a fast-evolving market. As a valued portfolio company of Valsoft, Anju Software serves a wide spectrum of clients in the pharmaceutical, biotechnology, and research sectors worldwide.